CD33 and type 1 diabetes mellitus: A study performed in T1D patients has shown that in peripheral blood mononuclear cells (PBMC) the frequency of CD11b+CD33+ MDSCs is significantly increased, but these MDSCs are not maximally suppressive in function, suggesting that functional defects in MDSCs may contribute to T1D pathogenesis [60].